北京招聘

?Develop and implement medical strategies / plans for responsible products, ensure strategic alignment with global strategy and local business needs
?Establish strong working relationships with key external stakeholders (eg, consultants, KOLs, health care professional societies)
?Lead on key medical initiated meetings, eg. medical advisory boards meetings, national scientific events
?Deliver /review high quality medical education/training materials for internal and external stakeholders
?In align with brand strategy and according to unmet medical needs, design, implement and manage post-marketing study / IIT to ensure scientific accuracy, GCP/ ethical compliance and publication plan
?In align with medical strategy, develop publication plan and ensure its implementation.
?As a core member of brand team, participate brand team meeting and provide medical insight to brand plan and strategy
?Review/approve promotional materials and ensures the materials fully align with sciences point of view
?Serve as medical/ science resources to other functions: Marketing, Regulatory, Market Access, Pharmacovigilance and Risk Management groups
?Works in a compliant manner and contributes to the culture of the wider team in up-skilling compliance skills
职位要求：
?Master degree or above in clinical medicine, pharmacy or life science
?At least 4 years of pharmaceutical industry experience in medical affairs / R&D
?If no experience of MA, at least 1 year experience of Sr. MSL
?Proven ability to design, interpret, discuss and represent clinical trial data and establish effective working relationship with investigators and KOLs
?Ability to write / edit scientific articles, posters and abstracts. - Ability to align key messages with clinical studies and publications
?Excellent interpersonal skills. Ability to work with internal and external stakeholders
?Excellent verbal and written communication and organizational skills
?Fluent in spoken and written English is required

百济神州是一家立足于科学的全球性生物科技公司，专注于开发创新、可负担的药物，旨在为全球患者改善治疗效果，提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作，加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。